ORCA Bio Inc.

Orca Bio is gearing up to commercialize Orca-T, the cell therapy it is developing for blood cancer patients as an alternative to traditional allogeneic stem cell transplant, as it prepares to apply fo

“We’re at an exciting juncture in medicine where the perceived scientific boundaries in treatment across therapeutic areas continue to dissolve.” These words from Jeffrey Jones , chief medical office

Having played such a crucial role for nearly three years in addressing the global COVID-19 pandemic, the pharma and biotech sectors are enjoying a return to something approaching normality. Neverthele

In recognition of the unprecedented accomplishments of the biopharmaceutical industry over the past couple years, the winners of the 2021 Citeline Awards include numerous contributions to the COVID-19